Načítá se...
PD-L1 Expression in Lung Cancer
Immunotherapies targeted against programmed death ligand 1 (PD-L1) and its receptor (PD-1) have improved survival in a subset of patients with advanced lung cancer. PD-L1 protein expression has emerged as a biomarker that predicts which patients are more likely to respond to immunotherapy. The under...
Uloženo v:
| Vydáno v: | J Thorac Oncol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5353357/ https://ncbi.nlm.nih.gov/pubmed/27117833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2016.04.014 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|